Cartesian Therapeutics Inc - RNAC - stock price prediction, stock price target, analyst ratings from 9 analysts

Cartesian Therapeutics Inc has a share price target of US$ 36, revenue growth forecast of -95.2%, and profit growth estimate of 31.0% for FY25, based on top 9 analyst calls.